Fulgent Genetics, Inc. FLGT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $320.35M-0.7% | $322.67M+2.3% | $315.55M+4.1% | $303.22M+3.7% | $292.45M+3.2% | ||
| $196.33M+2.4% | $191.8M+3.4% | $185.41M+2.0% | $181.82M+1.6% | $178.99M+1.6% | ||
| $124.02M-5.2% | $130.88M+0.6% | $130.14M+7.2% | $121.4M+7.0% | $113.46M+5.8% | ||
| 38.7%-1.8pp | 40.6%-0.7pp | 41.2%+1.2pp | 40%+1.2pp | 38.8%+1.0pp | ||
| $55.69M+3.3% | $53.91M+4.0% | $51.85M+4.2% | $49.77M0.0% | $49.78M+2.0% | ||
| $47.13M+8.7% | $43.37M+3.4% | $41.93M+6.4% | $39.41M+10.3% | $35.72M-1.4% | ||
| $119.06M+2.1% | $116.66M+17.4% | $99.36M+2.5% | $96.97M+5.5% | $91.91M+4.3% | ||
| $8.07M+0.5% | $8.03M+0.4% | $8M+0.4% | $7.97M0.0% | $7.97M0.0% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $229.94M+3.6% | $221.97M+10.4% | $201.14M+3.6% | $194.12M+4.7% | $185.37M+2.3% | ||
| $229.94M+3.6% | $221.97M+10.4% | $201.14M+3.6% | $194.12M+4.7% | $185.37M+2.3% | ||
| -$105.92M-16.3% | -$91.1M-28.3% | -$70.99M+2.4% | -$72.72M-1.1% | -$71.92M+2.7% | ||
| -33.1%-4.8pp | -28.2%-5.7pp | -22.5%+1.5pp | -24%+0.6pp | -24.6%+1.5pp | ||
| $78K+4.0% | $75K— | —— | —— | —— | ||
| $31.55M+2.0% | $30.92M-3.7% | $32.11M-0.7% | $32.32M+1.2% | $31.94M+2.0% | ||
| $21.64M+2.7% | $21.07M-5.1% | $22.2M+72.0% | $12.9M-42.4% | $22.4M+2.0% | ||
| -$84.28M-20.4% | -$70.03M-43.5% | -$48.8M+18.4% | -$59.82M-20.8% | -$49.51M+4.7% | ||
| -$9.27M-10.5% | -$8.39M-81.5% | -$4.63M+40.6% | -$7.78M-1.8% | -$7.64M+6.2% | ||
| -$73.81M-22.0% | -$60.51M-40.8% | -$42.98M+15.8% | -$51.02M-25.1% | -$40.78M+4.5% | ||
| -23%-4.3pp | -18.8%-5.1pp | -13.6%+3.2pp | -16.8%-2.9pp | -13.9%+1.1pp | ||
| -$2.39-21.9% | -$1.96-41.0% | -$1.39+16.3% | -$1.66-24.8% | -$1.33+5.7% | ||
| -$2.39-21.9% | -$1.96-41.0% | -$1.39+16.3% | -$1.66-24.8% | -$1.33+5.7% | ||
| 123M0.0% | 122.9M+0.4% | 122.4M+0.3% | 122M+0.4% | 121.6M+0.9% | ||
| 123M0.0% | 122.9M+0.4% | 122.4M+0.3% | 122M+0.4% | 121.6M+0.9% | ||
| -$2.39-21.9% | -$1.96-41.0% | -$1.39+16.3% | -$1.66-24.8% | -$1.33+5.7% | ||
| -$2.39-21.9% | -$1.96-41.0% | -$1.39+16.3% | -$1.66-24.8% | -$1.33+5.7% | ||
| $8.07M+0.5% | $8.03M+0.4% | $8M+0.4% | $7.97M0.0% | $7.97M0.0% | ||
| -$2.2M-81.3% | -$1.21M+17.6% | -$1.47M+50.3% | -$2.97M+10.4% | -$3.31M+11.3% | ||
| $351K-12.0% | $399K-10.7% | $447K-9.5% | $494K-9.4% | $545K+0.2% | ||
| —— | —— | —— | —— | -$146K+55.9% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $800K+45.5% | $550K— | —— | —— | —— | ||
| —— | —— | —— | $27.69M+24.1% | $22.31M+36.9% | ||
| $14.27M+60.2% | $8.91M— | —— | —— | —— | ||
| —— | —— | —— | —— | -$1.03M-416% | ||
| -$48.45M-228% | -$14.79M-1.4% | -$14.58M+0.8% | -$14.7M-11.3% | -$13.21M-173% | ||
| $94.58M-15.1% | $111.37M+53.1% | $72.76M— | —— | —— | ||
| —— | —— | —— | -$25.09M-368% | $9.36M-55.5% | ||
| —— | —— | -$13K+58.1% | -$31K— | —— | ||
| $95K-37.9% | $153K+31.9% | $116K-82.6% | $665K+5.6% | $630K+13.9% | ||
| —— | —— | —— | —— | —— | ||
| $5.35M+76.2% | $3.04M+7.2% | $2.83M-2.5% | $2.91M-6.4% | $3.1M+7.1% | ||
| —— | —— | —— | —— | $0— | ||
| $23.06M+2.1% | $22.57M+5.6% | $21.37M-38.7% | $34.86M-14.9% | $40.98M+1.6% | ||
| —— | —— | —— | —— | $57K-81.8% | ||
| —— | —— | —— | —— | $38.25K-25.0% | ||
| $6.76M-11.6% | $7.65M— | —— | —— | —— | ||
| $320.35M-0.7% | $322.67M+2.3% | $315.55M+4.1% | $303.22M+3.7% | $292.45M+3.2% | ||
| $38.92M-1.7% | $39.58M-2.8% | $40.71M-2.9% | $41.92M-3.7% | $43.51M-2.2% | ||
| -$105.92M-16.3% | -$91.1M-28.3% | -$70.99M+2.4% | -$72.72M-1.1% | -$71.92M+2.7% | ||
| -$81.72M-22.0% | -$66.97M-43.1% | -$46.79M+3.8% | -$48.64M-1.9% | -$47.73M+2.6% | ||
| -$81.72M-22.0% | -$66.97M-43.1% | -$46.79M+3.8% | -$48.64M-1.9% | -$47.73M+2.6% | ||
| -25.5%-4.8pp | -20.8%-5.9pp | -14.8%+1.2pp | -16%+0.3pp | -16.3%+1.0pp | ||
| -$105.92M-16.3% | -$91.1M-28.3% | -$70.99M+2.4% | -$72.72M-1.1% | -$71.92M+2.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Fulgent Genetics, Inc.'s revenue?
- Fulgent Genetics, Inc. (FLGT) generated $320.3M in revenue over the trailing twelve months, up 9.5% year over year.
- Is Fulgent Genetics, Inc. profitable?
- Fulgent Genetics, Inc. is not currently profitable: it reported a net loss of $73.8M over the trailing twelve months, a -23.0% net margin.
- What are Fulgent Genetics, Inc.'s profit margins?
- Gross margin is 38.7% and operating margin is -33.1%, with a -23.0% net margin.
- What is Fulgent Genetics, Inc.'s earnings per share?
- Fulgent Genetics, Inc.'s diluted EPS over the trailing twelve months is $-2.39.
- Where does Fulgent Genetics, Inc.'s income statement data come from?
- Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
